A heptavalent vaccine protecting against meningitis A and C was licensed in 2007.
预防甲型和丙型脑膜炎的七价疫苗于2007年获得许可。
A tetravalent meningococcal meningitis vaccine (licensed in the United States) and a heptavalent vaccine protecting against meningitis A and C (to be licensed in 2007);
一种四价流行性脑脊髓膜炎疫苗（已在美利坚合众国获许可证）和一种预防脑膜炎A和C的七价疫苗（将于2007年注册）；
Objective To provide a better cell model of closely nature infectious state for further understanding the immunopathogenesis, clinical treatment and vaccine development of hepatitis c.
目的为进一步研究丙型肝炎免疫发病机制、临床治疗和疫苗研制提供最接近自然感染状态的理想细胞模型。
Objective To provide a better cell model of closely nature infectious state for further understanding the immunopathogenesis, clinical treatment and vaccine development of hepatitis c.
目的为进一步研究丙型肝炎免疫发病机制、临床治疗和疫苗研制提供最接近自然感染状态的理想细胞模型。
应用推荐